Nuclear medicine in diagnosis and treatment of diseases of the head and neck. I. Salivary and parathyroid gland disease and one identification and staging of head and neck tumors.
The advent of both improved imaging systems and new radioactive agents has increased the effectiveness of nuclear medicine in diagnosing and treating diseases of the head and neck. In this first in a series of two articles, the role of nuclear medicine is discussed in the evaluation of diseases of the salivary and parathyroid glands, and in the identification and staging of head and neck tumors. Radionuclide studies of the salivary glands are useful in the identification of tumors and the evaluation of gland function. Such studies are a valuable adjunct in the diagnosis of Sjögren's syndrome and of acute and chronic inflammatory disease. Radionuclide imaging also has been helpful in the detection of adenomata and hyperplasia of the parathyroid glands and often complements ultrasonography localization procedures. The advent of gallium-67 imaging has improved the staging of head and neck tumors.
D005710:Gallium Radioisotopes; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D006801:Humans; D007457:Iodine Radioisotopes; D009367:Neoplasm Staging; D010279:Parathyroid Diseases / Q000000981:diagnostic imaging*; D011868:Radioisotopes; D011877:Radionuclide Imaging; D012466:Salivary Gland Diseases / Q000000981:diagnostic imaging* / Q000473:pathology / Q000503:physiopathology; D012507:Sarcoidosis / Q000000981:diagnostic imaging; D012643:Selenium; D012645:Selenomethionine; D012793:Sialadenitis / Q000000981:diagnostic imaging; D012859:Sjogren's Syndrome / Q000000981:diagnostic imaging; D013670:Sodium Pertechnetate Tc 99m; D013667:Technetium
D005710:Gallium Radioisotopes; D007457:Iodine Radioisotopes; D011868:Radioisotopes; D013667:Technetium; D012645:Selenomethionine; D013670:Sodium Pertechnetate Tc 99m; D012643:Selenium